US2006211102A1PendingUtilityA1

Human lysophosphatidic acid acyltransferase gamma-1 polypeptide

58
Assignee: CEEL THERAPEUTICS INCPriority: Mar 19, 1996Filed: May 25, 2006Published: Sep 21, 2006
Est. expiryMar 19, 2016(expired)· nominal 20-yr term from priority
Inventors:David LeungDaniel AdourelDavid Hollenback
C12N 9/1029
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Polypeptides are obtained, for example, via expression of encoding cDNA sequences, that have the activity of the enzyme lysophosphatidic acid acyltransferase (LPAAT), also known as 1-acyl sn-glycerol-3-phosphate acyltransferase.

Claims

exact text as granted — not AI-modified
1 . An isolated polypeptide having lysophosphatidic acid acyltransferase activity, comprising the amino acid sequence SEQ ID NO: 17.

Join the waitlist — get patent alerts

Track US2006211102A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.